How to Handle a Valuable Gift from a Patient as a Doctor

As a doctor, it is important to maintain a professional relationship with your patients. This includes being cautious about accepting gifts, especially those valued over £50. Here are some options for handling a valuable gift from a patient:

1. Return it to the patient and explain you cannot accept such a gift. This may cause embarrassment, but it is the most professional option.

2. Keep it and share it with your team. Explain to the patient that gifts over £50 should only be accepted on behalf of an organisation, not an individual staff member.

3. Give it to a charity. Be open and honest with the patient and suggest they donate the money to a charitable organisation.

4. Thank the patient and keep it. However, this could raise questions about your professionalism and could leave you vulnerable to criticism.

5. Thank the patient and use the money to buy something nice for the ward. While this is a kind gesture, the patient should directly give the money to the hospital and doctors should be cautious about accepting valuable gifts.

Remember, maintaining a professional relationship with your patients is crucial and accepting gifts should be done with caution.

The most likely diagnosis based on the examination findings is patent ductus arteriosus (PDA). To close the PDA, indomethacin (or ibuprofen) should be given to inhibit prostaglandin synthesis. Giving prostaglandin E1 would have the opposite effect and maintain the patency of the duct, which is not necessary in this scenario. Simply observing the neonate over time is not appropriate, and routine or urgent surgical referrals are not needed at this stage. First-line management should be to try medical closure of the PDA using indomethacin, which is effective in most cases.

Patent ductus arteriosus is a type of congenital heart defect that is typically classified as ‘acyanotic’. However, if left untreated, it can eventually lead to late cyanosis in the lower extremities, which is known as differential cyanosis. This condition is caused by a connection between the pulmonary trunk and descending aorta that fails to close with the first breaths due to increased pulmonary flow that enhances prostaglandins clearance. Patent ductus arteriosus is more common in premature babies, those born at high altitude, or those whose mothers had rubella infection during the first trimester of pregnancy.

The features of patent ductus arteriosus include a left subclavicular thrill, a continuous ‘machinery’ murmur, a large volume, bounding, collapsing pulse, a wide pulse pressure, and a heaving apex beat. To manage this condition, indomethacin or ibuprofen is given to the neonate, which inhibits prostaglandin synthesis and closes the connection in the majority of cases. If patent ductus arteriosus is associated with another congenital heart defect that is amenable to surgery, then prostaglandin E1 is useful to keep the duct open until after surgical repair.

Mothers often have concerns about the use of antiepileptic medication during and after pregnancy, particularly when it comes to breastfeeding. However, according to a comprehensive document released by the Royal College of Obstetricians and Gynaecologists, nearly all antiepileptic drugs are safe to use while breastfeeding. This is because only negligible amounts of the medication are passed to the baby through breast milk, and studies have not shown any negative impact on the child’s cognitive development. Therefore, it is recommended that mothers continue their current antiepileptic regime and are encouraged to breastfeed. It is important to note that stopping the medication without consulting a neurologist can lead to further seizures.

Pregnancy and breastfeeding can be a concern for women with epilepsy. It is generally recommended that women continue taking their medication during pregnancy, as the risks of uncontrolled seizures outweigh the potential risks to the fetus. However, it is important for women to take folic acid before pregnancy to reduce the risk of neural tube defects. The use of antiepileptic medication during pregnancy can increase the risk of congenital defects, but this risk is still relatively low. It is recommended to aim for monotherapy and there is no need to monitor drug levels. Sodium valproate is associated with neural tube defects, while carbamazepine is considered the least teratogenic of the older antiepileptics. Phenytoin is associated with cleft palate, and lamotrigine may require a dose increase during pregnancy. Breastfeeding is generally safe for mothers taking antiepileptics, except for barbiturates. Pregnant women taking phenytoin should be given vitamin K in the last month of pregnancy to prevent clotting disorders in the newborn.

A warning has been issued about the use of sodium valproate during pregnancy and in women of childbearing age. New evidence suggests a significant risk of neurodevelopmental delay in children following maternal use of this medication. Therefore, it should only be used if clearly necessary and under specialist neurological or psychiatric advice. It is important for women with epilepsy to discuss their options with their healthcare provider and make informed decisions about their treatment during pregnancy and breastfeeding.

The symptoms described strongly suggest thrombosed haemorrhoids, as the patient experiences pain during bowel movements and has a tender lump near the anus, along with rectal bleeding. Normally, haemorrhoids do not cause pain unless they are thrombosed.
If the patient seeks medical attention within 72 hours of the onset of pain, NICE recommends hospital admission for surgical treatment of the haemorrhoids to provide immediate relief from pain.
After the first 72 hours, the thrombus is likely to contract and resolve on its own within a few weeks. In such cases, conservative management options such as pain relief medication, stool softeners, and ice packs are more appropriate.
It is unlikely that the patient has perianal Crohn’s disease if they have no history of inflammatory bowel disease.
Perianal abscesses cause severe pain in the perianal area, but unlike thrombosed haemorrhoids, this pain is not necessarily associated with bowel movements. A visible lump may or may not be present, and there may be pus discharge if the abscess has ruptured, but blood is not typically seen.
While it is important to rule out more serious causes of rectal bleeding, referring the patient under a 2-week-wait rule would not address their current symptoms. It is more appropriate to investigate the underlying cause once the acute presentation has resolved.

Thrombosed haemorrhoids are characterized by severe pain and the presence of a tender lump. Upon examination, a purplish, swollen, and tender subcutaneous perianal mass can be observed. If the patient seeks medical attention within 72 hours of onset, referral for excision may be necessary. However, if the condition has progressed beyond this timeframe, patients can typically manage their symptoms with stool softeners, ice packs, and pain relief medication. Symptoms usually subside within 10 days.

Dipyridamole and its Effect on Myocardial Blood Flow

Dipyridamole has been found to decrease the flow of blood to specific regions of the heart, which could potentially lead to the occurrence of coronary steal phenomenon. This phenomenon happens when blood flow is diverted from healthy areas of the heart to areas that are already compromised due to reduced blood flow.

The reduction in regional myocardial blood flow caused by dipyridamole may be due to its ability to dilate blood vessels, which can lead to a decrease in blood pressure and flow. This effect can be beneficial in certain medical conditions, such as preventing blood clots, but it can also have negative consequences in patients with pre-existing heart disease.

It is important for healthcare providers to carefully consider the potential risks and benefits of using dipyridamole in patients with heart disease, as it may exacerbate existing issues. Close monitoring of patients receiving this medication is necessary to ensure that any adverse effects are promptly identified and addressed.

Differential diagnosis of abdominal symptoms

Abdominal symptoms can have various causes, and a careful differential diagnosis is necessary to identify the underlying condition. In this case, the patient presents with bloating, early satiety, urinary symptoms, and an elevated CA-125 level. Here are some possible explanations for these symptoms, based on their typical features and diagnostic markers.

Ovarian cancer: This is a possible diagnosis, given the mass effect on the gastrointestinal and urinary organs, as well as the elevated CA-125 level. However, ovarian cancer often presents with vague symptoms initially, and other conditions can also increase CA-125 levels. Anorexia and weight loss are additional symptoms to consider.

Colorectal cancer: This is less likely, given the absence of typical symptoms such as change in bowel habits, rectal bleeding, or anemia. The classical marker for colorectal cancer is CEA, not CA-125.

Irritable bowel syndrome: This is also less likely, given the age of the patient and the presence of urinary symptoms. Irritable bowel syndrome is a diagnosis of exclusion, and other likely conditions should be ruled out first.

Genitourinary prolapse: This is a possible diagnosis, given the urinary symptoms and the sensation of bulging or fullness. Vaginal spotting, pain, or irritation are additional symptoms to consider. However, abdominal bloating and early satiety are not typical, and CA-125 levels should not be affected.

Diverticulosis: This is unlikely, given the absence of typical symptoms such as altered bowel habits or left iliac fossa pain. Diverticulitis can cause rectal bleeding, but fever and acute onset of pain are more characteristic.

In summary, the differential diagnosis of abdominal symptoms should take into account the patient’s age, gender, medical history, and specific features of the symptoms. Additional tests and imaging may be necessary to confirm or exclude certain conditions.

Febrile convulsions are a common occurrence in young children, with up to 5% of children experiencing them. However, only a small percentage of these children will develop epilepsy. Risk factors for febrile convulsions include a family history of the condition and a background of neurodevelopmental disorder. The use of regular antipyretics has not been proven to decrease the likelihood of febrile convulsions.

Febrile convulsions are seizures caused by fever in children aged 6 months to 5 years. They typically last less than 5 minutes and are most commonly tonic-clonic. There are three types: simple, complex, and febrile status epilepticus. Children who have had a first seizure or any features of a complex seizure should be admitted to pediatrics. Regular antipyretics do not reduce the chance of a febrile seizure occurring. The overall risk of further febrile convulsion is 1 in 3, with risk factors including age of onset, fever duration, family history, and link to epilepsy. Children without risk factors have a 2.5% risk of developing epilepsy, while those with all three features have a much higher risk.

The most likely diagnosis for this case is reactive arthritis, which is a type of arthritis that occurs after a distant infection in the gastrointestinal or urogenital area. It is characterized by joint pain, urethritis, and uveitis, and is more common in individuals who have the HLA-B27 gene. The infections that commonly trigger reactive arthritis are caused by Salmonella, Shigella, Yersinia, and Campylobacter organisms.

Other possible diagnoses were ruled out based on the absence of certain symptoms. Behcet’s disease, which presents with oral and genital ulcers and uveitis, was unlikely due to the lack of ulcers or visual symptoms. Septic arthritis, which causes joint swelling and pain, was also considered but was less likely because it typically affects only one joint and is accompanied by fever and other signs. Systemic juvenile idiopathic arthritis and systemic lupus erythematosus were also considered but were ruled out due to the absence of their characteristic symptoms.

Reactive arthritis is a type of seronegative spondyloarthropathy that is associated with HLA-B27. It was previously known as Reiter’s syndrome, which was characterized by a triad of urethritis, conjunctivitis, and arthritis following a dysenteric illness during World War II. However, further studies revealed that patients could also develop symptoms after a sexually transmitted infection, now referred to as sexually acquired reactive arthritis (SARA). Reactive arthritis is defined as arthritis that occurs after an infection where the organism cannot be found in the joint. The post-STI form is more common in men, while the post-dysenteric form has an equal incidence in both sexes. The most common organisms associated with reactive arthritis are listed in the table below.

Management of reactive arthritis is mainly symptomatic, with analgesia, NSAIDs, and intra-articular steroids being used. Sulfasalazine and methotrexate may be used for persistent disease. Symptoms usually last for less than 12 months. It is worth noting that the term Reiter’s syndrome is no longer used due to the fact that Reiter was a member of the Nazi party.

Hyperventilation leads to a respiratory alkalosis (non-compensated) due to the reduction in carbon dioxide levels.

Disorders of Acid-Base Balance: An Overview

The acid-base normogram is a useful tool for categorizing the various disorders of acid-base balance. Metabolic acidosis is the most common surgical acid-base disorder, characterized by a reduction in plasma bicarbonate levels. This can be caused by a gain of strong acid (such as in diabetic ketoacidosis) or a loss of base (such as from bowel in diarrhea). Metabolic alkalosis, on the other hand, is usually caused by a rise in plasma bicarbonate levels, which can be due to problems of the kidney or gastrointestinal tract. Respiratory acidosis occurs when there is a rise in carbon dioxide levels, usually as a result of alveolar hypoventilation, while respiratory alkalosis results from hyperventilation, leading to excess loss of carbon dioxide.

Each of these disorders has its own set of causes and mechanisms. For example, metabolic alkalosis can be caused by vomiting/aspiration, diuretics, or primary hyperaldosteronism, among other factors. The mechanism of metabolic alkalosis involves the activation of the renin-angiotensin II-aldosterone (RAA) system, which causes reabsorption of Na+ in exchange for H+ in the distal convoluted tubule. Respiratory acidosis, on the other hand, can be caused by COPD, decompensation in other respiratory conditions, or sedative drugs like benzodiazepines and opiate overdose.

It is important to understand the different types of acid-base disorders and their causes in order to properly diagnose and treat them. By using the acid-base normogram and understanding the underlying mechanisms, healthcare professionals can provide effective interventions to restore balance to the body’s acid-base system.

The Importance of Stopping Medication Errors Immediately

Prescription errors are common in medicine, and patient safety is always a priority. In the event of a medication error, the most appropriate action is to stop the medication running immediately to prevent harm to the patient. It is also important to inform the patient of the error, as they may have a delayed reaction. Creating a Datix form to emphasize prescribing safety is also important, but it should not take precedence over stopping the medication. It is unprofessional to ignore the error or cross off the prescription and pretend it never happened. Admitting the error to the team is important for transparency, but stopping the prescription should be the first action taken. Overall, stopping medication errors immediately is crucial for ensuring patient safety.